Shares of Qiagen have rebounded after three years following a news report that the provider of biotech workflow solutions was evaluating strategic options, which include a potential sale.
Gallup poll shows AI use surging at work across industries—boosting productivity but raising risks for vulnerable roles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results